MabDesign’s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of cell therapies.

MabDesign’s market analyses give you a monthly overview of market dynamics and projects in development for a given indication or technology, to help you better understand the constantly evolving market of biologics and biomanufacturing. This month, an overview of the market and pipeline of therapeutic antibodies.

For five years, GenSensor has been on a mission to help bioproducers better understand and control what happens inside their fermenters and bioreactors, through cutting-edge biomarker monitoring GenSampler® is the next step in that journey: a fully automated sampling system that seamlessly integrates aseptic sampling and sample preparation, unlocking the full potential of advanced analytics

YUMAB is an innovative biotech company developing next-generation therapeutic antibodies for clients and partners worldwide. Their platform includes proprietary library technologies, such as fully human antibody libraries, patient-derived libraries, and immune libraries from different species. YUMAB integrates all technologies from discovery through engineering and AI-enabled lead optimization, providing developability-approved therapeutic lead candidates.